Efficacy of Tongfu Granules in Treatment of Grastrointestinal Dysfunction in Patients with Multiple Organ Dysfunction Syndromes: an Analysis of 140 Cases

Jun Dong,Shu-Wen Zhang,Mei-Li Duan,Bao-En Wang,Hong Wang,Cheng-Hong Yin,Yan Wen
DOI: https://doi.org/10.11569/wcjd.v14.i35.3358
2006-01-01
Abstract:AIM: To observe the effect of Tongfu granules on the intestinal dysfunction of patients with multiple organ dysfunction syndromes (MODS). METHODS: Prospective, multi-center and randomized controlled trial was used in this study. A total of 140 patients selected from the ICU of 10 hospitals in Beijing were randomly divided into group A and B, treated with Mosapride Citrate and Tongfu granules, respectively. The experimental indexes, including peristaltic sound, the condition of pneumatosis and fluid in intestine (performing abdominal B-type ultrasound), serum endotoxin, diamine oxidase (DAO), D-lactic acid were observed at the 0, 48 hour, and the 7 day after treatment (or before death), respectively, and the scores for intestinal dysfunction were compared between the two groups according to Lushan meeting criteria in 1995. RESULTS: At the 7 day after treatment, the ratio of peristaltic sound (beat/min), the positive ratio of abdominal B-type ultrasound for pneumatosis and fluid, the levels of serum endotoxin, serum DAO, serum D-lactic acid, and intestinal dysfunction scores were significantly different between group A and B (2.29 ± 1.685 vs 3.62 ± 1.762, P < 0.01; 34.4% vs 13.5%, P < 0.05; 180 ± 30 EU/L vs 111 ± 21 EU/L, P < 0.05; 4.45 ± 1.67 μkat/L vs 3.17 ± 0.83 μkat/L, P < 0.01; 14.594 ± 2.022 mg/L vs 10.49 ± 4.185 mg/L, P < 0.05; 0.41 ± 0.12 vs 1.32 ± 0.14, P < 0.01). CONCLUSION: Tongfu granules can obviously promote intestinal motility and improve intestinal mucosal barrier function.
What problem does this paper attempt to address?